Publication of A Common Understanding 2025

The Scottish Government has today published 'A Common Understanding 2025 – Working Together for the People of Scotland'. 

Today's publication 'A Common Understanding 2025 - Working Together for the People of Scotland' demonstrates the value of productive relationships between the pharmaceutical industry and other partners in Scotland and is also a toolkit to help create these relationships.

The ABPI worked with the Scottish Government and NHS Scotland in the creation of the document, which references the ABPI Code of Practice, and partnership working guidance elsewhere in the UK.

With the ‘triple helix’ of the NHS, academia, and the pharmaceutical industry working together, more can be delivered to improve care for people in Scotland than could be achieved by individual organisations working alone.

The practical elements feature:

  • a 10-step framework for setting up joint working initiatives,
  • useful templates such as a project initiation document
  • case studies of successful NHS-industry partnerships
  • information on governance requirements, transparency obligations, and legal considerations

Case studies from this document are also featured in the ABPI’s NHS-industry partnerships case study library.

Dr Amit Aggarwal, Medical Director at the ABPI said: “There are now scores of examples in Scotland where pharmaceutical companies and the NHS have been able to devise and run joint projects that improve the lives of patients.

“The Common Understanding is an important document that not only provides practical guidance for NHS and pharmaceutical teams when they want to work together, but also gives a level of reassurance that, when the circumstances are right, it is perfectly appropriate for people to share their different expertise to solve problems.”


Notes to Editors
[1] Read 'A Common Understanding 2025: Working together for the people of Scotland'. 

TAGS
  • Partnership

Last modified: 18 July 2025

Last reviewed: 18 July 2025

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.